SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Lasa Supergenerics Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
540702 INE670X01014 22.6180113 LASA 0 119.64 0 0 10
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales26.6624.3030.56
Other Operating Income0.000.000.00
Other Income 0.000.080.00
Total Income26.6624.3930.56
Total Expenditure 25.6123.2626.51
PBIDT1.061.134.05
Interest 0.440.560.37
PBDT0.620.573.68
Depreciation2.682.682.65
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.61-2.095.98
Reported Profit After Tax-1.46-0.02-4.95
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-1.46-0.02-4.95
    
EPS (Unit Curr.)-0.290.00-0.99
EPS (Adj) (Unit Curr.)-0.290.00-0.99
Calculated EPS (Unit Curr.)-0.290.00-0.99
Calculated EPS (Adj) (Unit Curr.)-0.290.00-0.99
Calculated EPS (Ann.) (Unit Curr.)-1.16-0.02-3.95
Calculated EPS (Adj) (Ann.) (Unit Curr.)-1.16-0.02-3.95
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity50.1050.1050.10
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)3.984.6513.25
PBDTM(%)2.332.3512.04
PATM(%)-5.48-0.08-16.20